Triple therapy versus dual-antiplatelet therapy for dolichoectatic vertebrobasilar fusiform aneurysms treated with flow diverters

Overview of attention for article published in Journal of NeuroInterventional Surgery, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 3,572 followers.

@BoomerNeuro @chenjared @cvsection @BAFOUND @SNISinfo Limited but available. See prior tweet. Also presented at WFITN in Kyoto this year https://t.co/VbGx2wJmHS

@chenjared @cvsection @BAFOUND @SNISinfo Treat with FD and triple therapy. Consent for high risk procedure. Don't coil. Give it time. https://t.co/VbGx2wJmHS

RT @UMassNeuroSurg: Check out the latest article on Triple therapy versus dual-antiplatelet therapy for dolichoectatic vertebrobasilar fusi…

Check out the latest article on Triple therapy versus dual-antiplatelet therapy for dolichoectatic vertebrobasilar fusiform aneurysms treated with flow diverters with our PGY3 Dr. Owusu-Adjei. https://t.co/Wk6P1T3qf3 #neurosurgery #residentlife #aneurys…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.